Karyopharm Therapeutics Inc. (25K0)
Market Closed
17 Jul, 20:00
XFRA 
€
7. 75
-0.05
-0.641%
€
146.18M Market Cap
- P/E Ratio
- Div Yield
11 Volume
-1.17 Eps
€ 7.8
Previous Close Want to track 25K0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Karyopharm Therapeutics Inc. (25K0) Statistics
Valuation metrics
Market Cap 146.18M
Enterprise value 309.76M
Trailing P/E (ttm) -0.33
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 1.05
Price/Book (mrq) -0.37
Enterprise Value/Revenue 2.38
Enterprise Value/EBITDA -4.29
Overview
Shares outstanding 18.31M
Float 18.1M
Shares short -
% Held by insiders 0.04%
% Held by institutions 0.78%
Average volume (10 days) 1.47K
Average volume (90 days) 1.21K
Price summary
52-Week low 3.18
52-Week high 9.25
Beta -
50-Day moving average 6.47
200-Day moving average 5.73
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 26 Feb 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -1.29%
Operating margin -0.76%
Operational effectiveness
Return on assets -0.41%
Return on equity 0.67%
Income Statement
Revenue (ttm) 130.04M
Revenue per share (ttm) 10.55
Quarterly revenue growth (yoy) 0.17%
Gross profit (ttm) 16.79M
EBITDA -72.21M
Net income to common (ttm) -167.77M
Diluted EPS (ttm) -14
Quarterly earnings growth (yoy) 0.32%
Balance Sheet
Total cash (mrq) 78.18M
Total cash per share (mrq) 4.13
Total debt (mrq) 255.34M
Total Debt/Equity (mrq) -0.87
Current ratio (mrq) 1.12%
Book value per share (mrq) -13.58
Cash Flow
Cash flow statement -159.81M
Levered free cash flow (LFCF) -196.04M
